Ovarian stimulation protocols for onco-fertilty patients

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 2, 2013, Pages 203-206

  Koch, Juliette ^a   Ledger, William ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Agonist trigger; Gonadotropin; Oncofertility; Ovarian hyperstimulation; Superovulation

Indexed keywords

ALKYLATING AGENT; CISPLATIN; CLOMIFENE; CYTOTOXIC AGENT; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; TAMOXIFEN;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; CRYOPRESERVATION; EMBRYO (ANATOMY); ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE FERTILITY; FOLLICULAR PHASE; HORMONAL THERAPY; HUMAN; LEUKEMIA; LYMPHOMA; MENSTRUAL CYCLE; OOCYTE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; OVARY STIMULATION; PATIENT ATTITUDE; PELVIS ABSCESS; PHYSICIAN ATTITUDE; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; REPRODUCTIVE PROCEDURE; REVIEW; SICKLE CELL ANEMIA; SUPEROVULATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSVAGINAL ECHOGRAPHY; VASCULITIS; VITRIFICATION;

ADULT; CRYOPRESERVATION; FEMALE; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREGNANCY; VITRIFICATION;

EID: 84878375213     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-9947-7     Document Type: Review

References (16)

1. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10:251-66.
2. Song WY, Sun YP, Jin HX, Xin ZM, Su YC, Chian RC. Clinical outcome of emergency egg vitrification for women when sperm extraction from the testicular tissues of the male partner is not successful. Syst Biol Reprod Med. 2011;57:210-3. doi: 10.3109/19396368.2011.566666.
3. Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010;25:2239-46. doi: 10.1093/humrep/deq146.
4. Kim TJ, Laufer LR, Hong SW. Vitrification of oocytes produces high pregnancy rates when carried out in fertile women. Fertil Steril. 2010;93:467-74. doi: 10.1016/j.fertnstert.2008.12.094.
5. Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Kort HI, Vajta G. The efficacy and safety of human oocyte vitrification. Semin Reprod Med. 2009;27:450-5. doi: 10.1055/s-0029-1241054.
6. Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Vajta G, et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentre study. Hum Reprod. 2012;27:1606-12.
7. Vajta G, Nagy ZP, Cobo A, Conceicao J, Yovich J. Vitrification in assisted reproduction: myths, mistakes, disbeliefs and confusion. Reprod Biomed Online. 2009;19(Suppl3):1-7.
8. Youssef MAFM, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011, Issue 1. Art. No.: CD008046. doi: 10.1002/14651858.CD008046.
9. Stowitzki T. Ovarian stimulation in cancer patients. European Society of Human Reproduction and Embryology Campus Workshop: Cancer and Fertility. Heidelberg Nov14-15th 2008.
10. Ozkaya E, San Roman G, Oktay K. Luteal phase GnRHa trigger in random start fertility preservation cycles. J Assist Reprod Gen. 2012;29:503-5.
11. Friedman BE, Pao S, Westphal LM, Lathi RB. Oocyte retrieveal following continued stimulation five days beyond ovulations yields live birth after frozen embryo transfer. J Assist Reprod Gen. 2012;29:433-5.
12. Kim SS, Donnez J, Barri P, et al. Recommendations for fertility preservation in patients with lymphoma, leukaemia and breast cancer. ISFP Practice Committee. J Assist Reprod Gen. 2012;29:465-8.
13. Checa Vizcaino MA, Chorchado AR, Cuadari ME, et al. The effects of letrazole on ovarian stimulation for fertility preservation in cancer-affected women. Reprod Biomed Online. 2012;24:606-10.
14. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrazole and gonadotropins in patients with breast cancer. J ClinOncol. 2008;26:2630-5.
15. Henes M, Henes JC, Neunhoeffer E, et al. Fertility preservation methods in young women with SLE prior to cytotoxic therapy: experiences from the FertiPROTEKT network. Lupus. 2012;21:953-8.
16. Peddie VL, Porter MA, Barbour R, et al. Factors affecting decision making about fertility preservation after cancer diagnosis: a qualitative study. BJObsGyn. 2012;119:1049-57.